NCT00302978

Brief Summary

We are interested in investigating the functional brain abnormalities of height phobia. Subjects will be have a functional MRI scan before and after a course of treatment with behavioral therapy.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2006

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2006

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

March 14, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 15, 2006

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2006

Completed
Last Updated

December 15, 2011

Status Verified

April 1, 2007

First QC Date

March 14, 2006

Last Update Submit

December 14, 2011

Conditions

Height PhobiaFear of Heights

Keywords

Height phobiafear of heightsspecific phobia

Outcome Measures

Primary Outcomes (1)

  • CGI

Secondary Outcomes (1)

  • acrophobia questionnaire

Interventions

Behavior therapyBEHAVIORAL

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Specific phobia of Heights

You may not qualify if:

  • History of medical problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

AcrophobiaPhobia, Specific

Interventions

Behavior Therapy

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Yujuan Choy, M.D.

    New York State Psychiatric Institute, Columbia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 14, 2006

First Posted

March 15, 2006

Study Start

March 1, 2006

Study Completion

June 1, 2006

Last Updated

December 15, 2011

Record last verified: 2007-04